FOLH1 and cancer: With the same PSMA aptamer [28], they created a more complex chimera (named PSEP) composed of a bivalent PSMA aptamer and a dual siRNA against EGFR and survivin, two important oncogenes that intersect multiple pathways involved in cancer [31].